Pathophysiology of cancer cachexia: Much more than host–tumour interaction?
- 1 December 2007
- journal article
- review article
- Published by Elsevier in Clinical Nutrition
- Vol. 26 (6) , 667-676
- https://doi.org/10.1016/j.clnu.2007.03.011
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Elevated tumour interleukin-1β is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancerBritish Journal of Cancer, 2006
- The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladderBritish Journal of Cancer, 2006
- Cancer cachexia and fatigueClinical Medicine, 2006
- Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight lossThe International Journal of Biochemistry & Cell Biology, 2005
- Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment GroupSupportive Care in Cancer, 2005
- Modulation of autonomic balance by tumors and virusesMedical Hypotheses, 2004
- “Starve a fever and feed a cold”: feeding and anorexia may be adaptive behavioral modulators of autonomic and T helper balanceMedical Hypotheses, 2004
- Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factorBritish Journal of Surgery, 2000
- Elevated energy expenditure in cancer patients with solid tumoursEuropean Journal of Cancer and Clinical Oncology, 1991
- Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition.Journal of Clinical Investigation, 1987